Subtype
Malignant Large Intestinal Neoplasm
CI-CAN-00003173Explore in graph →
1,622 active trials21 approved drugs383 evidence items
- NCIt
- C215202
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003173Explore in graph →
Clinical trials
7,502 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (742)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00893503 | Scope Pilot Research Study(SCOPE) | completed | — | 1,248 | University of AlbertaOTHER | 1 | Mar 8, 2011 | clinicaltrials |
| NCT00040820 | Oxaliplatin in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer | completed | N/A | — | Roswell Park Cancer InstituteOTHER | 1 | Mar 7, 2011 | clinicaltrials |
| NCT00900835 | Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung Cancer | completed | N/A | 470 | City of Hope Medical CenterOTHER | 1 | Mar 7, 2011 | clinicaltrials |
| NCT01305980 | Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Colorectal Cancer | unknown | Phase 2 | 30 | SBPharmaceutical IND, Co., LTDINDUSTRY | 1 | Mar 4, 2011 | clinicaltrials |
| NCT00118755 | A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 435 | Hoffmann-La RocheINDUSTRY | 0 | Mar 3, 2011 | clinicaltrials |
| NCT00977613 | Adherence to a Recommended Exercise Regimen in Colorectal Cancer Patients | completed | N/A | 50 | Beth Israel Medical CenterOTHER | 1 | Mar 3, 2011 | clinicaltrials |
| NCT00950144 | Studying Pain and Symptom Distress in Patients With Advanced Colon Cancer, Rectal Cancer, Pancreatic Cancer, or Liver Cancer | completed | — | 123 | City of Hope Medical CenterOTHER | 1 | Mar 2, 2011 | clinicaltrials |
| NCT01303393 | Information Needs After Surgery for Colorectal Cancer | completed | — | 100 | Region SkaneOTHER | 1 | Feb 24, 2011 | clinicaltrials |
| NCT01282658 | Pharmacogenomics Study of CPT-11 as the First-line Chemotherapy for mCRC(PSIFL) | unknown | — | 200 | Huazhong University of Science and TechnologyOTHER | 1 | Feb 17, 2011 | clinicaltrials |
| NCT01157806 | Palliative Radiochemotherapy Against Palliative Surgery in Stage IV Rectal Cancer With Unresectable Metastases | unknown | Phase 2 | 20 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Feb 16, 2011 | clinicaltrials |
| NCT01183156 | Re-invitation to Screening Colonoscopy: a Randomized Study(REINVITE) | unknown | N/A | 1,000 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Feb 16, 2011 | clinicaltrials |
| NCT00192075 | A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid Versus Avastin + Oxaliplatin + 5FU/Folinic Acid in Metastatic Colorectal Cancer | completed | Phase 2 | 84 | Eli Lilly and CompanyINDUSTRY | 1 | Feb 7, 2011 | clinicaltrials |
| NCT00007618 | The Identification of Prognostic Factors of Late Stage Disease, Particularly Those That Are Modifiable, That Might Explain the Worsened Prognosis With Colorectal Cancer Among Veterans. | completed | — | — | US Department of Veterans AffairsFED | 1 | Feb 3, 2011 | clinicaltrials |
| NCT00441311 | Dissemination of Colorectal Cancer Screening to Primary Care Physicians | completed | Phase 4 | 264 | Columbia UniversityOTHER | 1 | Feb 1, 2011 | clinicaltrials |
| NCT01286064 | Colorectal Cancer Detection by Means of Optical Fluoroscopy | unknown | N/A | 200 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Jan 31, 2011 | clinicaltrials |
| NCT01286662 | A Cohort Study of Patients Treated With Brachytherapy for Selected Desmoid Patients in Gardner Syndrome | completed | — | 105 | Triemli HospitalOTHER | 0 | Jan 31, 2011 | clinicaltrials |
| NCT00003365 | Sulindac and Plant Compounds in Preventing Colon Cancer | terminated | N/A | — | University of Medicine and Dentistry of New JerseyOTHER | 1 | Jan 27, 2011 | clinicaltrials |
| NCT00233623 | Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal Cancer | withdrawn | Phase 2 | 190 | AstraZenecaINDUSTRY | 1 | Jan 27, 2011 | clinicaltrials |
| NCT00207051 | BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal Malignancies | completed | Phase 1 | 62 | Bristol-Myers SquibbINDUSTRY | 3 | Jan 25, 2011 | clinicaltrials |
| NCT00113776 | Evaluating ABX-EGF Extended Therapy in Subjects With MetastaticColorectal Cancer | completed | Phase 2 | — | AmgenINDUSTRY | 0 | Jan 21, 2011 | clinicaltrials |
| NCT01279278 | Does the Invitation by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening?(Pagedocc1) | unknown | N/A | 2,700 | University of Paris 5 - Rene DescartesOTHER | 1 | Jan 19, 2011 | clinicaltrials |
| NCT01279330 | Does the Recall by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening?(Pagedocc2) | unknown | N/A | 1,569 | University of Paris 5 - Rene DescartesOTHER | 1 | Jan 19, 2011 | clinicaltrials |
| NCT00145314 | FLOX in Combination With Cetuximab in First-line Treatment of Colorectal Cancer | completed | Phase 3 | 571 | The Nordic Colorectal Cancer Biomodulation GroupOTHER | 1 | Jan 14, 2011 | clinicaltrials |
| NCT01271166 | Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal Cancer | terminated | Phase 1 | 10 | Novartis PharmaceuticalsINDUSTRY | 1 | Jan 6, 2011 | clinicaltrials |
| NCT01271192 | Efficacy and Safety Study of Neoadjuvant in Treating Patients With Resectable Local Recurrent Rectal Cancer(NARC) | unknown | N/A | 360 | Sun Yat-sen UniversityOTHER | 1 | Jan 6, 2011 | clinicaltrials |
| NCT00191984 | A Study of the Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal Cancer | completed | Phase 2 | 46 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 5, 2011 | clinicaltrials |
| NCT00410579 | Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers | completed | — | 744 | NSABP Foundation IncNETWORK | 1 | Dec 17, 2010 | clinicaltrials |
| NCT01261962 | Modulation of Immune Response by Oral Zinc Supplementation in Chemotherapy for Colon Cancer | unknown | N/A | 60 | University of Sao PauloOTHER | 1 | Dec 17, 2010 | clinicaltrials |
| NCT01262417 | Resorbable Barrier for the Prevention of Abdominal and Peri-hepatic Adhesion Formation(SEPRAC2T) | completed | Phase 2 | 60 | Centre Leon BerardOTHER | 1 | Dec 17, 2010 | clinicaltrials |
| NCT01251237 | Study to Assess the Tolerability, Safety and Efficacy of an Adapted Gut Cleansing Solution in Routine Colon Cleansing Prior to Colonoscopies | completed | Phase 2 | 120 | NorgineINDUSTRY | 1 | Dec 1, 2010 | clinicaltrials |
| NCT00228189 | Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer Patients | completed | Phase 1 / Phase 2 | 30 | Radboud University Medical CenterOTHER | 1 | Nov 30, 2010 | clinicaltrials |
| NCT00784667 | Dual Inhibition of EGFR Signalling Using the Combination of Cetuximab and Erlotinib(Dux) | unknown | Phase 2 | 50 | Austin HealthOTHER_GOV | 1 | Nov 30, 2010 | clinicaltrials |
| NCT01249521 | Dual Targeting of Vascular Endothelial Growth Factor-A Together With Angiopoietins in Chemotherapy-naïve Metastatic Colorectal Cancer(Vengeance) | unknown | Phase 2 | 40 | Austin HealthOTHER_GOV | 1 | Nov 30, 2010 | clinicaltrials |
| NCT00386828 | Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer Trial | completed | Phase 2 | 43 | British Columbia Cancer AgencyOTHER | 1 | Nov 25, 2010 | clinicaltrials |
| NCT01144195 | A Clinical Trial of Panitumumab in Combination With FOLFIRI Chemotherapy as Second Line Treatment in Subjects With Metastatic Colorectal Cancer Expressing Wild-type KRAS and Who Had Progressed ≥ 6 Months After the Last Dose of the First Line Chemotherapy(ACTIVE) | unknown | Phase 2 | 80 | Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socialsOTHER | 1 | Nov 10, 2010 | clinicaltrials |
| NCT00254137 | Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer. | completed | Phase 2 | 92 | Ludwig-Maximilians - University of MunichOTHER | 0 | Oct 28, 2010 | clinicaltrials |
| NCT01211379 | The FLU-FOBT Program in Primary Care Settings Where Disparities Persist | completed | N/A | 1,372 | University of California, San FranciscoOTHER | 1 | Oct 18, 2010 | clinicaltrials |
| NCT00230646 | Promoting Physical Activity After Colorectal Cancer | completed | Phase 3 | 46 | The Miriam HospitalOTHER | 1 | Oct 5, 2010 | clinicaltrials |
| NCT01212718 | Response Prediction in Metastasized Colorectal Cancer Using Intratumoral Thymidylate Synthase(FOGT5) | completed | Phase 2 | 168 | University of UlmOTHER | 1 | Oct 1, 2010 | clinicaltrials |
| NCT01211132 | Cap Assisted Colonoscopy for the Detection of Colon Polyps | unknown | N/A | 462 | American Society for Gastrointestinal EndoscopyOTHER | 1 | Sep 29, 2010 | clinicaltrials |
| NCT00414492 | Pattern of Cell Death Following Neoadjuvant Therapy for Metastatic Colon Cancer | completed | — | 100 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Sep 16, 2010 | clinicaltrials |
| NCT01193452 | S-1/Leucovorin (SL) Versus sLV5FU2 as the First-line Treatment for Elderly Patients With Colorectal Cancer | unknown | Phase 2 | 100 | Fudan UniversityOTHER | 1 | Sep 2, 2010 | clinicaltrials |
| NCT00102024 | Safety and Activity of 90Y-Labeled IDEC-159 in Subjects With Metastatic Colorectal Adenocarcinoma | terminated | Phase 1 / Phase 2 | 30 | BiogenINDUSTRY | 1 | Aug 27, 2010 | clinicaltrials |
| NCT00963352 | Colon Cancer Prognosis After Radical Surgery | unknown | — | 300 | Haraldsplass Deaconess HospitalOTHER | 1 | Aug 27, 2010 | clinicaltrials |
| NCT01186081 | Comparison of Preoperative and Postoperative Radiotherapy and Capecitabine in Locally Advanced Rectal Cancer | completed | Phase 3 | 240 | Asan Medical CenterOTHER | 1 | Aug 23, 2010 | clinicaltrials |
| NCT00469443 | Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC | completed | Phase 3 | 330 | Hellenic Oncology Research GroupOTHER | 1 | Aug 19, 2010 | clinicaltrials |
| NCT00345761 | Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer | completed | Phase 1 / Phase 2 | 64 | Chugai PharmaceuticalINDUSTRY | 1 | Aug 16, 2010 | clinicaltrials |
| NCT01181557 | A Questionnaire to Assess the Quality of Life of Rectal Cancer Patients With or Without Stoma | completed | — | 236 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Aug 13, 2010 | clinicaltrials |
| NCT00772083 | Caring for Those Who Share: Improving the Health of Wisconsin Blood Donors | completed | N/A | 400 | Medical College of WisconsinOTHER | 1 | Aug 11, 2010 | clinicaltrials |
| NCT00423254 | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. | completed | Phase 1 | 12 | Mannkind CorporationINDUSTRY | 1 | Aug 3, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Mar 8, 2011source: clinicaltrials